Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    veranova-m-2025-06-30

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    pulmoza

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 82571-53-7, Ozagrel [inn], Oky-046, (e)-3-(4-((1h-imidazol-1-yl)methyl)phenyl)acrylic acid, Ozagrel free acid, Kct-0809
    Molecular Formula
    C13H12N2O2
    Molecular Weight
    228.25  g/mol
    InChI Key
    SHZKQBHERIJWAO-AATRIKPKSA-N
    FDA UNII
    L256JB984D
    Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid
    2.1.2 InChI
    InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+
    2.1.3 InChI Key
    SHZKQBHERIJWAO-AATRIKPKSA-N
    2.1.4 Canonical SMILES
    C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O
    2.1.5 Isomeric SMILES
    C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    L256JB984D
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-2-propenoic Acid

    2. 4-(1-imidazoylmethyl)cinnamic Acid

    3. Oky 046

    4. Oky-046

    5. Ozagrel, Monohydrochloride

    6. Ozagrel, Monohydrochloride, (e)-isomer

    7. Sodium Ozagrel

    2.3.2 Depositor-Supplied Synonyms

    1. 82571-53-7

    2. Ozagrel [inn]

    3. Oky-046

    4. (e)-3-(4-((1h-imidazol-1-yl)methyl)phenyl)acrylic Acid

    5. Ozagrel Free Acid

    6. Kct-0809

    7. Domenan

    8. (e)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic Acid

    9. Chembl11662

    10. (e)-p-(imidazol-1-ylmethyl)cinnamic Acid

    11. L256jb984d

    12. 82571-53-7 (free Base)

    13. Ozagrel (inn)

    14. Ozagrelum [latin]

    15. Pulmoza

    16. Ozagrelum

    17. 3-[4-(1h-imidazol-1-ylmethyl)phenyl]-2e-propenoic Acid

    18. 2-propenoic Acid, 3-[4-(1h-imidazol-1-ylmethyl)phenyl]-, (2e)-

    19. Unii-l256jb984d

    20. Cataclot (tn)

    21. Ozagrel,(s)

    22. Ozagrel, Oky-046

    23. Ozagrel [mi]

    24. 2-propenoic Acid, 3-(4-(1h-imidazol-1-ylmethyl)phenyl)-, (e)-

    25. 3-[4-(1-imidazolylmethyl)phenyl]-2-propenoic Acid

    26. Ozagrel [mart.]

    27. Prestwick2_000979

    28. Prestwick3_000979

    29. Ozagrel [who-dd]

    30. Schembl4210

    31. Bspbio_001017

    32. Bpbio1_001119

    33. Gtpl9866

    34. Oky046

    35. Zinc5389

    36. Dtxsid6048547

    37. Chebi:92359

    38. Chebi:134938

    39. Hms2089o14

    40. Hms3649m21

    41. Hms3884n21

    42. Bcp12147

    43. Ex-a5744

    44. Hy-b0428

    45. Bdbm50017896

    46. Mfcd00868231

    47. S2496

    48. Akos015889403

    49. Ac-2080

    50. Ccg-266782

    51. Db12017

    52. Ncgc00025195-02

    53. As-71327

    54. Ls-14195

    55. Sbi-0207081.p001

    56. Ab00514722

    57. Sw197369-5

    58. 3-(4-imidazol-1-ylmethyl-phenyl)-acrylic Acid

    59. D08327

    60. (e)-3-(4-((1h-imidazol-1-yl)methyl)phenyl)

    61. Ab00514722-10

    62. Ab00514722-12

    63. Ab00514722-13

    64. Ab00514722_14

    65. Ab00514722_15

    66. 4-(1h-imidazole-1-ylmethyl)benzenepropenoic Acid

    67. 571o537

    68. (e)-3-(4-imidazol-1-ylmethyl-phenyl)-acrylic Acid

    69. Q-100843

    70. Q7116436

    71. Sr-01000597793-8

    72. 3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic Acid

    73. Brd-k19525698-003-01-1

    74. Brd-k53061490-003-03-0

    75. (e)-3-[4-(1h-imidiazol-1-ylmethyl)phenyl]-2-propenic Acid

    76. (2e)-3-[4-(1h-imidazol-1-ylmethyl)phenyl]acrylic Acid

    77. (2e)-3-{4-[(1h-imidazol-1-yl)methyl]phenyl}prop-2-enoic Acid

    78. (e)-3-[p-(1h-imidazol-1-ylmethyl)phenyl]-2-propenoic Acid

    2.4 Create Date
    2005-03-25
    3 Chemical and Physical Properties
    Molecular Weight 228.25 g/mol
    Molecular Formula C13H12N2O2
    XLogP31.6
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count3
    Rotatable Bond Count4
    Exact Mass228.089877630 g/mol
    Monoisotopic Mass228.089877630 g/mol
    Topological Polar Surface Area55.1 Ų
    Heavy Atom Count17
    Formal Charge0
    Complexity283
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Histamine Antagonists

    Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)

    Enzyme Inhibitors

    Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

    Fibrinolytic Agents

    Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. (See all compounds classified as Fibrinolytic Agents.)